Cargando…

Case report: Implantable cardioverter-defibrillator implantation with optimal medical treatment for lethal ventricular arrhythmia caused by recurrent coronary artery spasm due to tyrosine kinase inhibitors

Coronary artery spasm (CAS) may induce lethal ventricular arrhythmia due to severe and prolonged vessel constriction. Tyrosine kinase inhibitors are associated with the occurrence of CAS. Optimal medical treatment is the first-line therapeutic option for the management of CAS, whereas patients who e...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Jifu, Xia, Guang, Luo, Yu, Cai, Ying, Huang, Ying, Yang, Zhiyun, Yang, Qinghui, Yang, Bing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045981/
https://www.ncbi.nlm.nih.gov/pubmed/36998979
http://dx.doi.org/10.3389/fcvm.2023.1145075
_version_ 1785013551586344960
author Jin, Jifu
Xia, Guang
Luo, Yu
Cai, Ying
Huang, Ying
Yang, Zhiyun
Yang, Qinghui
Yang, Bing
author_facet Jin, Jifu
Xia, Guang
Luo, Yu
Cai, Ying
Huang, Ying
Yang, Zhiyun
Yang, Qinghui
Yang, Bing
author_sort Jin, Jifu
collection PubMed
description Coronary artery spasm (CAS) may induce lethal ventricular arrhythmia due to severe and prolonged vessel constriction. Tyrosine kinase inhibitors are associated with the occurrence of CAS. Optimal medical treatment is the first-line therapeutic option for the management of CAS, whereas patients who experienced aborted sudden cardiac death (SCD) may benefit from implantable cardioverter-defibrillator (ICD) implantation. We report a case of a 63-year-old Chinese man receiving tyrosine kinase inhibitor treatment for liver cancer who presented with recurrent chest discomfort and syncope with an elevation of high-sensitivity troponin T. Emergent coronary angiography showed sub-total occlusion of the left anterior descending artery without other signs of CAS. Percutaneous transluminal coronary angioplasty with a drug-coated balloon was performed successfully with the guidance of intravascular ultrasound. After 5 months, the patient returned to the emergency room for chest discomfort and another episode of syncope. The electrocardiogram showed ST-segment elevation in the inferior and V5–V6 leads compared to the previous event. Coronary angiography was repeated immediately and showed significant luminal stenosis at the midportion of the right coronary artery (RCA), whereas, after administration of intracoronary nitroglycerine, a remarkable recovery of RCA patency was noticed. A diagnosis of CAS was made, and soon after that, the patient rapidly developed ventricular arrhythmia in the coronary care unit. After successful resuscitation, the patient recovered completely and received long-acting calcium channel blockers as well as nitrates therapy. ICD implantation was performed considering the high risk of recurrence of life-threatening ventricular arrhythmia. During the follow-up period, the patient has been free of angina, syncope, or ventricular arrhythmia, and ICD interrogation showed no ventricular tachycardia or ventricular fibrillation. We first reported the case of a patient with CAS induced by regorafenib treatment complicated with severe atherosclerotic coronary disease who survived from sudden cardiac arrest. ICD implantation is indicated in patients who experienced aborted SCD for the prevention of the next lethal ventricular arrhythmia.
format Online
Article
Text
id pubmed-10045981
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-100459812023-03-29 Case report: Implantable cardioverter-defibrillator implantation with optimal medical treatment for lethal ventricular arrhythmia caused by recurrent coronary artery spasm due to tyrosine kinase inhibitors Jin, Jifu Xia, Guang Luo, Yu Cai, Ying Huang, Ying Yang, Zhiyun Yang, Qinghui Yang, Bing Front Cardiovasc Med Cardiovascular Medicine Coronary artery spasm (CAS) may induce lethal ventricular arrhythmia due to severe and prolonged vessel constriction. Tyrosine kinase inhibitors are associated with the occurrence of CAS. Optimal medical treatment is the first-line therapeutic option for the management of CAS, whereas patients who experienced aborted sudden cardiac death (SCD) may benefit from implantable cardioverter-defibrillator (ICD) implantation. We report a case of a 63-year-old Chinese man receiving tyrosine kinase inhibitor treatment for liver cancer who presented with recurrent chest discomfort and syncope with an elevation of high-sensitivity troponin T. Emergent coronary angiography showed sub-total occlusion of the left anterior descending artery without other signs of CAS. Percutaneous transluminal coronary angioplasty with a drug-coated balloon was performed successfully with the guidance of intravascular ultrasound. After 5 months, the patient returned to the emergency room for chest discomfort and another episode of syncope. The electrocardiogram showed ST-segment elevation in the inferior and V5–V6 leads compared to the previous event. Coronary angiography was repeated immediately and showed significant luminal stenosis at the midportion of the right coronary artery (RCA), whereas, after administration of intracoronary nitroglycerine, a remarkable recovery of RCA patency was noticed. A diagnosis of CAS was made, and soon after that, the patient rapidly developed ventricular arrhythmia in the coronary care unit. After successful resuscitation, the patient recovered completely and received long-acting calcium channel blockers as well as nitrates therapy. ICD implantation was performed considering the high risk of recurrence of life-threatening ventricular arrhythmia. During the follow-up period, the patient has been free of angina, syncope, or ventricular arrhythmia, and ICD interrogation showed no ventricular tachycardia or ventricular fibrillation. We first reported the case of a patient with CAS induced by regorafenib treatment complicated with severe atherosclerotic coronary disease who survived from sudden cardiac arrest. ICD implantation is indicated in patients who experienced aborted SCD for the prevention of the next lethal ventricular arrhythmia. Frontiers Media S.A. 2023-03-14 /pmc/articles/PMC10045981/ /pubmed/36998979 http://dx.doi.org/10.3389/fcvm.2023.1145075 Text en Copyright © 2023 Jin, Xia, Luo, Cai, Huang, Yang, Yang and Yang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Jin, Jifu
Xia, Guang
Luo, Yu
Cai, Ying
Huang, Ying
Yang, Zhiyun
Yang, Qinghui
Yang, Bing
Case report: Implantable cardioverter-defibrillator implantation with optimal medical treatment for lethal ventricular arrhythmia caused by recurrent coronary artery spasm due to tyrosine kinase inhibitors
title Case report: Implantable cardioverter-defibrillator implantation with optimal medical treatment for lethal ventricular arrhythmia caused by recurrent coronary artery spasm due to tyrosine kinase inhibitors
title_full Case report: Implantable cardioverter-defibrillator implantation with optimal medical treatment for lethal ventricular arrhythmia caused by recurrent coronary artery spasm due to tyrosine kinase inhibitors
title_fullStr Case report: Implantable cardioverter-defibrillator implantation with optimal medical treatment for lethal ventricular arrhythmia caused by recurrent coronary artery spasm due to tyrosine kinase inhibitors
title_full_unstemmed Case report: Implantable cardioverter-defibrillator implantation with optimal medical treatment for lethal ventricular arrhythmia caused by recurrent coronary artery spasm due to tyrosine kinase inhibitors
title_short Case report: Implantable cardioverter-defibrillator implantation with optimal medical treatment for lethal ventricular arrhythmia caused by recurrent coronary artery spasm due to tyrosine kinase inhibitors
title_sort case report: implantable cardioverter-defibrillator implantation with optimal medical treatment for lethal ventricular arrhythmia caused by recurrent coronary artery spasm due to tyrosine kinase inhibitors
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045981/
https://www.ncbi.nlm.nih.gov/pubmed/36998979
http://dx.doi.org/10.3389/fcvm.2023.1145075
work_keys_str_mv AT jinjifu casereportimplantablecardioverterdefibrillatorimplantationwithoptimalmedicaltreatmentforlethalventriculararrhythmiacausedbyrecurrentcoronaryarteryspasmduetotyrosinekinaseinhibitors
AT xiaguang casereportimplantablecardioverterdefibrillatorimplantationwithoptimalmedicaltreatmentforlethalventriculararrhythmiacausedbyrecurrentcoronaryarteryspasmduetotyrosinekinaseinhibitors
AT luoyu casereportimplantablecardioverterdefibrillatorimplantationwithoptimalmedicaltreatmentforlethalventriculararrhythmiacausedbyrecurrentcoronaryarteryspasmduetotyrosinekinaseinhibitors
AT caiying casereportimplantablecardioverterdefibrillatorimplantationwithoptimalmedicaltreatmentforlethalventriculararrhythmiacausedbyrecurrentcoronaryarteryspasmduetotyrosinekinaseinhibitors
AT huangying casereportimplantablecardioverterdefibrillatorimplantationwithoptimalmedicaltreatmentforlethalventriculararrhythmiacausedbyrecurrentcoronaryarteryspasmduetotyrosinekinaseinhibitors
AT yangzhiyun casereportimplantablecardioverterdefibrillatorimplantationwithoptimalmedicaltreatmentforlethalventriculararrhythmiacausedbyrecurrentcoronaryarteryspasmduetotyrosinekinaseinhibitors
AT yangqinghui casereportimplantablecardioverterdefibrillatorimplantationwithoptimalmedicaltreatmentforlethalventriculararrhythmiacausedbyrecurrentcoronaryarteryspasmduetotyrosinekinaseinhibitors
AT yangbing casereportimplantablecardioverterdefibrillatorimplantationwithoptimalmedicaltreatmentforlethalventriculararrhythmiacausedbyrecurrentcoronaryarteryspasmduetotyrosinekinaseinhibitors